The combination of biotransformations and metal‐assisted catalysis within hybrid systems represents a promising strategy to extend the repertoire of reactions enabled in a biomolecular environment. Both covalent catalytic entities and supramolecular assemblies have been created recently to mediate transformations otherwise difficult to perform in ‘classical’ biocatalysis. In this context, various biopolymers can serve as ligand spheres simultaneously acting as chiral inducers. In particular, modular approaches embedding novel metal‐based catalytic centers via an affinity interaction are highly appealing, as this technology may serve as a versatile platform to incorporate diverse reactivities in a biological matrix in a stereoselective fashion.
No takes yet. Share an insight, caveat, or question.
Marko D. Mihovilovič (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: